Boniface Omara
CEO, Founder & FAS Fellow
A Biomedical Laboratory Technologist with expertise in molecular biology and bioinformatics, with published first-author research in antiviral peptide discovery.
About
Building a resilient future for African health.
An African biotechnology venture designing antiviral peptides for diseases that have gone without treatment.
What we do
Mara Biosciences is an African biotechnology venture developing AI-guided antiviral peptide therapeutics for emerging infectious diseases. We combine computational biology, artificial intelligence, and wet laboratory science to accelerate therapeutic discovery for pathogens that have historically received limited commercial attention, starting with the Sudan ebolavirus, for which there is currently no approved drug.
Mission
Accelerate the discovery of antiviral therapeutics for diseases affecting Africa.
Vision
A future where African-led biotechnology delivers globally relevant medicines.
Team & Advisors
Led by specialists in bioinformatics and biotechnology.
Dr. Hedmon Okella
Ph.D. — Scientific Advisor
Expert in molecular biology and peptide development.
Dr. Steven Odongo
Ph.D., Lecturer — Scientific Advisor
Expert in molecular microbiology and nanotechnology.
Our advisory board and mentors provide deep technical guidance in virology and peptide sciences, ensuring our platform remains at the forefront of global scientific standards.
Supported by
Contact
Let's Build the Next Generation of Antivirals
Whether you are a researcher, funding organisation, biotechnology company or global health partner, we would love to explore collaboration.